Can Quetiapine (Seroquel) Help Treat Akathisia?
Yes, quetiapine can help treat akathisia and is specifically recommended as a treatment option by switching to it from other antipsychotics that cause akathisia. 1
Guideline-Based Recommendations
The most recent international guidelines (2025) explicitly state that akathisia can be managed by switching to quetiapine or olanzapine 1. This represents a clear, evidence-based strategy where quetiapine serves as an akathisia-sparing antipsychotic rather than just an adjunctive treatment.
The American Psychiatric Association guidelines (2020) provide a broader framework for akathisia management, suggesting three options: lowering the antipsychotic dose, switching to another antipsychotic, adding a benzodiazepine, or adding a beta-blocker 2. However, the 2025 guidelines are more specific in identifying quetiapine as a preferred switch option.
Clinical Evidence Supporting Quetiapine's Role
Quetiapine has one of the lowest akathisia rates among all antipsychotics:
- In first-episode psychosis patients, quetiapine had only a 3.5% incidence of akathisia compared to haloperidol (57%), risperidone (20%), aripiprazole (18.2%), and ziprasidone (17.2%) 3
- Only olanzapine (3.6%) had a comparable low rate 3
- A dose-response meta-analysis found that quetiapine carried negligible risk for akathisia across all examined doses with a flat dose-response curve 4
- In bipolar mania trials, quetiapine's akathisia incidence (3.3%) was similar to placebo (6.1%) 5
FDA Label Information
The FDA label for Seroquel confirms low akathisia rates in clinical trials:
- In bipolar depression studies, akathisia occurred in 4% of quetiapine patients vs. 1% on placebo 6
- In adolescent schizophrenia trials, akathisia rates were 4.8% for quetiapine vs. 4.0% for placebo 6
Practical Treatment Algorithm
When a patient develops akathisia on another antipsychotic:
First-line approach: Switch to quetiapine (or olanzapine) as these are the only true akathisia-sparing second-generation antipsychotics 1, 3
Alternative approaches if switching is not feasible:
Dosing considerations: Quetiapine's akathisia-sparing effect appears consistent across the dose range, as the dose-response curve remains flat 4
Important Caveats
- Quetiapine is not typically used as an adjunctive treatment for akathisia caused by other antipsychotics—it works by being the primary antipsychotic instead
- The mechanism likely relates to quetiapine's lower D2 receptor affinity and broader receptor profile compared to higher-potency antipsychotics
- While one case report suggested quetiapine as part of combination therapy for cathinone-induced akathisia, this was ineffective 7, highlighting that quetiapine works best when it replaces the offending agent rather than being added to it
- Treatment-resistant akathisia may require combination approaches including beta-blockers, benzodiazepines, or emerging evidence for mirtazapine 8, 9
Quality of Life Impact
Akathisia is severely distressing and can lead to medication non-adherence, worsening psychosis, and even suicidality. Switching to quetiapine addresses both the underlying psychiatric condition and eliminates the akathisia, making it a superior strategy compared to adding multiple medications to manage side effects while continuing the offending antipsychotic.